Compare COYA & SBFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COYA | SBFG |
|---|---|---|
| Founded | 2020 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.6M | 134.8M |
| IPO Year | 2022 | 2014 |
| Metric | COYA | SBFG |
|---|---|---|
| Price | $4.00 | $20.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.80 | N/A |
| AVG Volume (30 Days) | ★ 120.6K | 8.6K |
| Earning Date | 05-12-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.03% |
| EPS Growth | N/A | ★ 27.33 |
| EPS | N/A | ★ 2.19 |
| Revenue | ★ $7,945,753.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,050.79 | N/A |
| P/E Ratio | ★ N/A | $9.35 |
| Revenue Growth | ★ 123.57 | N/A |
| 52 Week Low | $3.71 | $17.10 |
| 52 Week High | $7.75 | $23.93 |
| Indicator | COYA | SBFG |
|---|---|---|
| Relative Strength Index (RSI) | 37.61 | 47.41 |
| Support Level | $3.94 | $19.69 |
| Resistance Level | $5.16 | $20.83 |
| Average True Range (ATR) | 0.25 | 0.49 |
| MACD | -0.03 | 0.10 |
| Stochastic Oscillator | 30.92 | 43.23 |
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
SB Financial Group Inc that provides a range of community banking services, including commercial and consumer lending, personal and business banking, treasury management and merchant services, personal wealth management and brokerage services, and other financial services to individuals, businesses, and municipalities. It operates in single segment which is Banking.